vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and NACCO INDUSTRIES INC (NC). Click either name above to swap in a different company.
NACCO INDUSTRIES INC is the larger business by last-quarter revenue ($66.8M vs $62.1M, roughly 1.1× Cytek Biosciences, Inc.). NACCO INDUSTRIES INC runs the higher net margin — -5.8% vs -70.9%, a 65.2% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -5.2%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 11.9%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
NACCO Industries, Inc. is an American publicly traded holding company, headquartered in Cleveland, Ohio. Through a portfolio of mining and natural resources businesses, the company operates under three business segments: Coal Mining, North American Mining, and Minerals Management. The Coal Mining segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The North American Mining se...
CTKB vs NC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $66.8M |
| Net Profit | $-44.1M | $-3.8M |
| Gross Margin | 52.9% | 18.0% |
| Operating Margin | -9.0% | 11.3% |
| Net Margin | -70.9% | -5.8% |
| Revenue YoY | 8.1% | -5.2% |
| Net Profit YoY | -557.1% | -150.8% |
| EPS (diluted) | — | $-0.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $66.8M | ||
| Q3 25 | $52.3M | $76.6M | ||
| Q2 25 | $45.6M | $68.2M | ||
| Q1 25 | $41.5M | $65.6M | ||
| Q4 24 | $57.5M | $70.4M | ||
| Q3 24 | $51.5M | $61.7M | ||
| Q2 24 | $46.6M | $52.3M | ||
| Q1 24 | $44.9M | $53.3M |
| Q4 25 | $-44.1M | $-3.8M | ||
| Q3 25 | $-5.5M | $13.3M | ||
| Q2 25 | $-5.6M | $3.3M | ||
| Q1 25 | $-11.4M | $4.9M | ||
| Q4 24 | $9.6M | $7.6M | ||
| Q3 24 | $941.0K | $15.6M | ||
| Q2 24 | $-10.4M | $6.0M | ||
| Q1 24 | $-6.2M | $4.6M |
| Q4 25 | 52.9% | 18.0% | ||
| Q3 25 | 52.7% | 13.0% | ||
| Q2 25 | 52.3% | 10.0% | ||
| Q1 25 | 48.6% | 14.7% | ||
| Q4 24 | 58.5% | 12.0% | ||
| Q3 24 | 56.3% | 11.7% | ||
| Q2 24 | 54.6% | 13.4% | ||
| Q1 24 | 51.3% | 13.2% |
| Q4 25 | -9.0% | 11.3% | ||
| Q3 25 | -17.6% | 8.8% | ||
| Q2 25 | -23.3% | -0.1% | ||
| Q1 25 | -36.1% | 11.7% | ||
| Q4 24 | 5.2% | 5.5% | ||
| Q3 24 | -8.2% | 31.9% | ||
| Q2 24 | -18.3% | 14.1% | ||
| Q1 24 | -23.9% | 8.9% |
| Q4 25 | -70.9% | -5.8% | ||
| Q3 25 | -10.5% | 17.3% | ||
| Q2 25 | -12.2% | 4.8% | ||
| Q1 25 | -27.5% | 7.5% | ||
| Q4 24 | 16.8% | 10.7% | ||
| Q3 24 | 1.8% | 25.4% | ||
| Q2 24 | -22.4% | 11.4% | ||
| Q1 24 | -13.8% | 8.6% |
| Q4 25 | — | $-0.53 | ||
| Q3 25 | — | $1.78 | ||
| Q2 25 | — | $0.44 | ||
| Q1 25 | — | $0.66 | ||
| Q4 24 | — | $0.99 | ||
| Q3 24 | — | $2.14 | ||
| Q2 24 | — | $0.81 | ||
| Q1 24 | — | $0.61 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $49.7M |
| Total DebtLower is stronger | — | $100.8M |
| Stockholders' EquityBook value | $341.7M | $429.2M |
| Total Assets | $461.5M | $661.2M |
| Debt / EquityLower = less leverage | — | 0.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $49.7M | ||
| Q3 25 | $93.3M | $52.7M | ||
| Q2 25 | $75.5M | $49.4M | ||
| Q1 25 | $95.3M | $61.9M | ||
| Q4 24 | $98.7M | $72.8M | ||
| Q3 24 | $162.3M | $63.1M | ||
| Q2 24 | $177.9M | $62.4M | ||
| Q1 24 | $168.8M | $61.8M |
| Q4 25 | — | $100.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $99.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $29.0M | ||
| Q1 24 | — | $28.4M |
| Q4 25 | $341.7M | $429.2M | ||
| Q3 25 | $378.6M | $426.4M | ||
| Q2 25 | $377.6M | $413.1M | ||
| Q1 25 | $379.6M | $409.1M | ||
| Q4 24 | $395.7M | $404.9M | ||
| Q3 24 | $385.5M | $397.3M | ||
| Q2 24 | $389.1M | $384.1M | ||
| Q1 24 | $392.6M | $381.6M |
| Q4 25 | $461.5M | $661.2M | ||
| Q3 25 | $494.9M | $637.6M | ||
| Q2 25 | $493.3M | $631.3M | ||
| Q1 25 | $482.6M | $634.2M | ||
| Q4 24 | $499.5M | $631.7M | ||
| Q3 24 | $491.2M | $597.4M | ||
| Q2 24 | $483.7M | $560.1M | ||
| Q1 24 | $492.1M | $538.0M |
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 0.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $11.4M |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $11.4M | ||
| Q3 25 | $-3.9M | $42.3M | ||
| Q2 25 | $108.0K | $-7.8M | ||
| Q1 25 | $-125.0K | $5.0M | ||
| Q4 24 | $2.0M | $25.2M | ||
| Q3 24 | $13.2M | $2.8M | ||
| Q2 24 | $6.2M | $4.1M | ||
| Q1 24 | $4.0M | $-9.8M |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.19× | ||
| Q2 25 | — | -2.39× | ||
| Q1 25 | — | 1.03× | ||
| Q4 24 | 0.21× | 3.33× | ||
| Q3 24 | 14.05× | 0.18× | ||
| Q2 24 | — | 0.68× | ||
| Q1 24 | — | -2.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
NC
| Transferred Over Time | $42.7M | 64% |
| Transferred At Point In Time | $24.1M | 36% |
